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Clinical and pathologic features of fibrillary glomerulonephritis. A
diagnosis of fibrillary glomerulonephritis was made in 31 renal biopsies
from 28 patients on the basis of the electron microscopic identification
of glomerular deposits of randomly arranged fibrils that resembled
amyloidosis but were larger. This accounted for approximately 1% of all
nontranspiant renal biopsy diagnoses. Renal biopsy specimens with
parallel arrays of 30 nm to 50 nm microtubules (that is, immunotactoid
glomerulopathy) were not included in the study. The patients had a
mean age of 49 years with a range of 21 to 75. The male to female ratio
was 1:1.8 and the ratio of Whites to Blacks was 8.3:1, which differs from
the 3:1 ratio in our overall biopsy population. All patients had protein-
uria (mean 6.0 g/day), and most had hematuria and renal insufficiency.
After a mean follow-up of 24 months, there was 48% renal survival. The
light microscopic appearance of the fibrillary glomerulonephritis was
quite varied. Capillary wall thickening and matrix expansion were the
most frequent alterations. Nineteen percent of specimens had cres-
cents. Morphometric ultrastructural analysis demonstrated a mean fibril
diameter of 22.4 7.4 nm. Immunofluorescence microscopy revealed
that IgG was the dominant and often the only immunoglobulin class in
immune deposits, and subclass analysis revealed that IgG4 was the
dominant or exclusive subclass in all specimens tested. We hypothesize
that the relatively homogeneous nature of the immunoglobulin in the
immune deposits is the basis for the fibril formation.
In 1977 Rosenmann and Eliakim reported a glomerulopathy
characterized by infiltration of glomeruli by a fibrillar material
that resembled amyloid but did not stain with Congo red [1].
Similar cases have subsequently been reported by many inves-
tigators 12—24]. In a report of a series of patients with this
disease, Duffy et a! used the term fibrillary to describe the
characteristic ultrastructure of the immune deposits [4]. Fol-
lowing this precedent, Alpers et al adopted the term fibrillary
glomerulonephritis for this disease [10]. A distinctly different
form of glomerulopathy characterized by larger microtubular
structures within immune deposits was described by Schwartz
and Lewis in 1980, and named immunotactoid glomerulopathy
[25]. This same pattern of glomerular immune deposition has
been reported by other investigators [9, 16, 19, 22, 23, 26—32].
There has been a lack of uniformity in the use of these terms,
with some investigators using the term fibrillary glomerulone-
phritis for both patterns of diseases, and others using the term
immunotactoid glomerulopathy for both. As will be explained
further in the Discussion, we agree with those who advocate
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using the term fibrillary glomerulonephritis for specimens con-
taining the smaller diameter fibrils and immunotactoid glomer-
ulopathy for specimens containing the larger diameter microtu-
bules [22, 32].
We have studied the pathologic and clinical features of
fibrillary glomerulonephritis in 28 patients, including ultrastruc-
tural morphometric analysis of the fibrils and immunohistologic
characterization of the subclass composition of the deposited
IgG. Specimens with parallel arrays of larger diameter micro-
tubular structures within the immune deposits (that is, immu-
notactoid glomerulopathy) were excluded from this study.
Our data confirm that the ultrastructural and immunohisto-
logic features are distinctive enough to be used to confidently
differentiate fibrillary glomerulonephritis from other forms of
glomerular disease. They also indicate that the immunoglobulin
composition of the immune deposits is predominantly IgG4.
Methods
A diagnosis of fibrillary glomerulonephritis was made on the
basis of the ultrastructural identification of glomerular infiltrates
of randomly arranged fibrils that were larger than amyloid
fibrils, and dissimilar from the even larger parallel microtubular
arrays that will be considered later when immunotactoid glom-
erulopathy is discussed. The 31 renal biopsy specimens with a
diagnosis of fibrillary glomerulonephritis were all accessioned
into the database of the Glomerular Disease Collaborative
Network, which has its coordinating center at the University of
North Carolina at Chapel Hill. These specimens were derived
from 4,145 native kidney biopsies. The frequency of fibrillary
glomerulonephritis was compared to other diseases identified in
3,785 consecutive nontranspiant renal biopsies evaluated by the
University of North Carolina Nephropathology Laboratory.
Clinical data were provided by the primary care nephrologists
or obtained by medical chart review or patient encounters.
Renal survival estimates were calculated by the Kaplan-Meir
life table method.
All specimens were studied by conventional light, immuno-
fluorescence and electron microscopy procedures. Paraffin-
embedded sections were stained with hematoxylin and eosin,
periodic acid-Schiff, Jones silver and Masson's trichrome
stains. Ten specimens were stained with Congo red.
For direct immunofluorescence microscopy, specimens were
stained with commercial antisera to human IgG, IgA, 1gM, C3,
Cl q, and kappa and lambda immunoglobulin light chains (Whit-
taker Bioproducts, Walkersville, Maryland, USA). Thirteen
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Fig. 1. Electron micrograph demonstrating fibrils predominantly in the subepithelia! zone of a glomerular capillary from a patient with fibrillary
glomerulonephritis (x30,000).
specimens also were examined by immunofluorescence micros-
copy for IgG subclasses with biotinylated mouse monoclonal
antibodies to human IgGi, IgG2, IgG3, IgG4 (Binding Site Inc.,
San Diego and Zymed Laboratories Inc., San Francisco, Cali-
fornia, USA) as primary antibodies and fluoresceinated Strepta-
vidin (Zymed) as the detector. Reactivity of IgG subclass
reagents in an immunofluorescence microscopy assay was
documented against B lymphocytes and plasma cells in frozen
sections of lymphoid tissue, and specificity was confirmed
against monoclonal IgG immunoglobulins by enzyme-linked
immunosorbent assay. Subclass distribution in fibrillary gb-
merulonephritis was compared to that in 13 diffuse proliferative
lupus glomerulonephritis and seven membranous glomerulopa-
thy specimens.
For electron microscopy, tissue was fixed in glutaraldehyde,
postfixed in osmium tetroxide and embedded in Polybed 512.
Silver colored ultrathin sections were stained with acetate and
lead citrate and examined with a Philips 400 electron micro-
scope. Measurement of fibril thickness in 18 specimens was
carried out on electron micrographs representing 2.6x enlarge-
ment of original exposures taken at 15,200x magnification.
Accuracy of the measurements was checked by comparison
with a carbon grating with 2,160 crossed lines/mm (0.463
sm/line, Ernest Fullam, Lathan, New York, USA). In each
case the thickness of 10 randomly selected fibrils that had
sharply defined outlines were measured. Measurements were
taken with a hand-held illuminated measuring magnifier (Peak
scale loupe 7x, Polysciences, Warrington, Pennsylvania,
USA). The actual transverse diameters were calculated taking
into account the enlargement and magnification factors. For
comparison purposes, measurements were also taken on elec-
tron micrographs from four patients with classic amyboidosis.
Results
Electron microscopy
The sine qua non for a diagnosis of fibrillary glomerulone-
phritis specimens was the presence of randomly aligned fibrils
that resembled amyloid fibrils but were larger (Figs. 1, 2A). One
patient who had two biopsies five years apart, and one patient
who had three biopsies in three consecutive years showed
continued presence of ultrastructurally identical fibrillary de-
posits.
Morphometric analysis of fibrils in 18 specimens of fibrillary
gbomerulonephritis revealed a mean fibril diameter of 22.2 nm
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Fig. 2. Comparison of the differences in ultra structural appearance between fibrillary glomerulonephriris (A), amyloidosis (B), accentuated native
matrix fibrils (C), and immunotactoid glomerulopathy (D). (X15,000).
dominance of fibrils of approximately 20 nm diameter, these
were admixed with lesser numbers of fibrils mostly in the range
of 15 nm to 30 nm. This contrasts with the four amyloidosis
specimens in which the range of fibril thickness was approxi-
mately 8 to 15 nm and the mean was 10.6 nm with a standard
deviation of 2.9 nm. Figures 2A and 2B contrast the fibrils of
fibrillary glomerulonephritis and amyloidosis. The fibrils of
fibrillary glomerulonephritis were larger and straighter than the
fibrils that are occasionally observed in mesangial matrix in
patients without glomerular immune deposits (Fig. 2C). The
approximately 20 nm diameter fibrils of fibrillary glomerulone-
phritis were clearly distinguishable from the larger diameter
microtubular structures within the immune deposits of cryo-
globulinemic glomerulopathy and so-called immunotactoid
glomerulopathy, which will be elaborated on in the Discussion
(Fig. 2D).
Fibrils were observed in all glomerular compartments, in-
cluding mesangium, basement membrane, subendothelial zone,
subepithelial zone, and Bowman's capsule. In all patients, at
least some involvement of both mesangium and capillary walls
could be identified. Most patients had substantial capillary wall
infiltration, especially in the subepithelial zone, but a few
specimens had predominantly mesangial involvement. Approx-
imately a quarter of the specimens had poorly delineated areas
of increased density associated with the fibrillary deposits, but
none of the cases had well defined immune complex-type dense
deposits containing the fibrils.
Immunofluorescence microscopy
Immunofluorescence microscopy demonstrated positive
staining for immunoglobulins in 30 of 31 specimens. In one
patient the staining was exclusively mesangial, in 12 it was
predominantly mesangial with segmentally variable capillary
wall staining (Fig. 3A), and in 17 the staining was diffuse and
global involving capillary walls and mesangium (Fig. 3B). The
capillary wall, and to a lesser degree, the mesangial staining had
relatively distinctive appearances compared to other types of
immune complex deposition. The capillary wall staining was
ribbon or band-like rather than granular, and the mesangial
staining was confluent with irregular margins.
The frequency and intensity of immunofluorescence micros-
copy findings are detailed in Tables 1 and 2. All but one of the
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Fig. 3. Immunofluorescence microscopy of predominantly mesangial staining (A) and combined capillary wall and mesangial staining (B)
resulting from IgG deposition in fibrillary glomerulonephritis (fluoresceinated anti-IgG, x500).
Table 1. Observations by immunofluorescence microscopy in 31 renal
biopsies from 28 patients with fibrillary glomerulonephritis




IgG 31 97% 3.5+
1gM 31 61% 0.8+
IgA 30 37% 0.9+
C3 31 97% 2.5+
Clq 30 30% 1.3+
kappa 26 96% 3.0+
lambda 26 84% 3.0+
specimens had substantial degrees of immunostaining for IgG
with a mean intensity of 3.5 + on a scale of 0 to 4+. Staining for
1gM was present in 61% of specimens at a mean intensity of
0.8+ with only 10% of specimens having greater than 1 +
staining. Staining for IgA was present in 37% with only 15%
having greater than 1 + IgA. Of 26 specimens evaluated for light
chain immunostaining, kappa chains were present in all of the
cases that had immunoglobulin staining, and only three cases
had kappa light chains without lambda light chains.
As shown in Table 2, immunostaining was practically re-
stricted to the IgG4 subclass, All cases stained intensely for
IgG4 (mean intensity 3.2+). Only 15% of specimens stained
weakly for IgGi, and no specimens stained for IgG2 or IgG3.
These results indicate a striking homogeneity of the immuno-
globulin within the deposits in fibrillary glomerulonephritis. In
order to ensure that this was not caused by differences in the
avidity and sensitivity of the monoclonal antibodies used in
detecting the different subclasses, 13 cases of diffuse prolifera-
tive lupus glomerulonephritis and 17 cases of mernbranous
glomerulopathy were also examined (Table 2). The proliferative
lupus glomerulonephritis specimens had a dominance of IgG3
and IgGI, and membranous glomerulopathy a dominance of
IgG4, although not as pronounced as that in fibrillary glomeru-
lonephritis.
Table 2. IgG subclass analysis in 13 patients with fibrillary
glomerulonephritis compared to patients with diffuse proliferative















IgG 100% 100% 3.7+
IgGl 15% 0% 0.8+ 0%
IgG2 0% 0% 0.0+ 0%
IgG3 0% 0% 0.0+ 0%





IgG 100% 100% 2.9+
IgGl 100% 62% 1.6+ 0%
IgG2 77% 0% 0.7+ 0%
IgG3 100% 100% 2.5+ 77%a
IgG4 77% 8% 1.0+ 0%
Membranous
glomerulopathy(N =7)
IgG 100% 100% 3.9+
IgGI 15% 14% 0.8+ 0%
IgG2 14% 14% 2.0+ 0%
IgG3 71% 43% 1.6+ 14%
IgG4 100% 100% 2.4+ 86%
The remaining 33% had equa! staining for IgGi and IgG3
Light microscopy
The light microscopic appearance of fibrillary glomerulone-
phritis was quite heterogeneous. As indicated in Table 3 gb-
merular capillary wall thickening, mesangial matrix expansion
and hypercellularity were the most frequent histologic abnor-
malities. Different degrees and combinations of these changes
resulted in marked histologic differences among the specimens.
Iskandar et at: Features of fibrillary glomerulonephritis 1405






Histologic features on hematoxylin and eosin stained sections
produced appearances ranging from that of membranous glom-
erulopathy to mesangioproliferative glomerulonephritis to
membranoproliferative glomerulonephritis to crescentic gb-
merulonephritis. Nineteen percent of specimens had crescent
formation with glomerular involvement ranging from 10% to
80%. None of the 10 specimens stained positive with Congo
red.
Three-fourths of the specimens had some degree of arterio-
sclerosis, which ranged in severity from mild to severe. Inter-
stitial fibrosis, tubular atrophy and interstitial infiltration of
mononuclear leukocytes was commensurate with the degree of
glomerular disease, that is, those patients with marked glomer-
ular injury had more severe tubulointerstitial changes than
those with mild glomerular injury.
Frequency among patients undergoing renal biopsy
The frequency with which fibrillary glomerulonephritis oc-
curs in patients who undergo nontransplant renal biopsy was
compared to that for several other well-known renal diseases.
Among 3,785 consecutive renal biopsy specimens evaluated by
the University of North Carolina Nephropathology Laboratory,
30 had fibrillary glomerulonephritis (0.8%), 450 membranous
glomerulopathy (11.9%), 202 IgA nephropathy (5.3%), 74 type I
membranoproliferative glomerulonephritis (2.0%), 45 amyboid-
osis (1.2%), 25 anti-glomerular basement membrane glomerulo-
nephritis (0.7%), and 4 type II membranoproliferative glomer-
ulonephritis (dense deposit disease) (0.1%). Therefore, in
patients with clinical indications for renal biopsy, fibrillary
glomerubonephritis has a similar frequency to anti-glomerular
basement membrane antibody-mediated gbomerulonephritis,
and is much more frequent than type II membranoproliferative
glomerulonephritis (dense deposit disease).
Clinical data
As shown in Table 4, at the time of diagnosis, the patients
with fibrillary glomerubonephritis had a mean age of 49 years,
but the age range at recognition extended from 21 to 75 years.
The disease was significantly more frequent than expected
among Whites than Blacks (P < 0.02) with a ratio of 8.3:1
compared to approximately 3:1 in our overall biopsy popula-
tion. The most common clinical feature was the nephrotic
syndrome. Most patients also had hematuria and renal insuffi-
ciency. Half of the patients had hypertension or were being
treated for hypertension at the time of diagnosis. Of 17 patients
tested for anti-nuclear antibodies, only two were positive. None
of 14 patients who had complement levels measured had
hypocomplementemia. No patients had extrarenal manifesta-
Age years 49 13.5 (range 21—75) 28
Sex 10 males/l8 females (1:1.8) 28
Race 25 White/3 Black (8.3:1) 28
Proteinuria 100% 28
Urine protein g/24 hr 6.0 3.6 (range 0.4—13.8) 22
Hematuria 67% 24
Serum creatinine mg/dI 3.7 4.3 (range 1.0—16.4) 27
Serum albumin gIdi 3.3 0.8 (range 1.7—4.4) 17
Cholesterol mg/d! 297 99 (range 138—524) 14
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Fig. 4. Renal survival curve for fibrillaiy glomerulonephritis patients
followed for a mean of 24 months.
tions of disease, including no features of lymphoproliferative
disease, systemic amyboidosis, vasculitis, pulmonary disfunc-
tion or hepatic dysfunction.
Life table analysis of the development of end-stage renal
disease (that is, requiring dialysis or transplantation) is depicted
in Figure 4. The mean renal survival after an average follow-up
of 24 months was only 48%. All but four patients had developed
at least some degree of renal insufficiency. Six patients received
varied regimens of corticosteroid treatment. Life table analysis
of the treated group compared to the untreated group demon-
strated no difference in progress to renal failure. The small
number of patients studied and the uncontrolled nature of the
treatment, however, preclude a definite conclusion about the
benefits of steroid treatment in patients with fibrillary glomer-
ulonephritis.
Discussion
Rosenmann and Eliakim provided the first description of a
gbomerulopathy characterized by infiltration of glomeruli by a
fibrillar material that resembled amyloid but did not stain with
Congo red or thioflavin-T [1]. The electron micrographs in that
report demonstrate glomerular lesions essentially identical to
those in the 31 renal biopsies from our 28 patients (Fig. 2A), as
Table 3. Light microscopic features observed in 31 renal biopsies
from 28 patients with fibrillary glomerulonephritis
% With
abnormality
Table 4. Clinical and laboratory data obtained at the time of renal
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Table 5. Differences in the ultrastructural appearance of amyloidosis,
fibrillary glomerulonephritis and immunotactoid glomerulopathy
Approximate
fiber diameter Orientation Diagnosis
10 nm Random Amyloidosis
20 nm Random Fibrillary glomerulonephritis
30—40 nm Parallel Immunotactoid glomerulopathy
well as many cases published by other investigators [2—241. The
first large series of patients with this disease was published in
1983 by Duffy et al and included eight patients [4]. These
authors used the term fibrillary to describe the ultrastructure of
the deposits. In a 1987 report of seven cases, Alpers et al
applied the term fibrillary glomerulonephritis to this disease
[101.
An ultrastructurally different pattern of glomerular immune
deposition characterized by parallel arrays of larger diameter
microtubules (Fig. 2D) was described in 1980 by Schwartz and
Lewis, and designated immunotactoid glomerulopathy [25].
Subsequent articles have reported additional cases with this
distinctive microtubular ultrastructure [9, 16, 19, 22, 23, 26—32].
Some reports have contained both cases with the fibrillary
deposits and cases with the microtubular deposits [9, 16, 19, 22,
23].
There has been disagreement over the nomenclature of
fibrillary glomerulonephritis and immunotactoid glomerulopa-
thy. We agree with those who conclude that the ultrastructural
patterns illustrated in Figures lA and 1D are clearly different,
and that the clinical features of these diseases also are different
[22, 32]. We also agree that, based on literature precedence, the
disease with approximately 20 nm diameter randomly-oriented
fibrillary deposits should be called fibrillary glomerulonephritis
[4, 101, and the disease with parallel arrays of larger microtu-
bules should be called immunotactoid glomerulopathy [25].
The 31 renal biopsies evaluated in this study had immune
deposits with very similar ultrastructural and immunohistologic
features, but quite different histologic appearances that corre-
lated to a degree with the distribution of immune deposits. For
example, specimens with predominantly mesangial immune
deposits had primarily mesangiopathic changes histologically,
and cases with extensive capillary wall deposits had more
pronounced capillary wall thickening and sometimes more
substantial hypercellularity. The clinical manifestations in our
patients were similar to those in other reports of fibrillary
glomerulonephritis, with nephrotic syndrome, hematuria, and
renal insufficiency being the most consistent abnormalities.
Our ultrastructural morphometric analysis yielded a mean
fibril diameter of approximately 20 nm (Table 5), which is
similar to that reported by other investigators. The most inter-
esting pathologic observation in our patients was the relative
homogeneity of the immunoglobulin within the immune depos-
its. As reviewed by Alpers [32], only a small minority of
patients with fibrillary glomerulonephritis have monoclonal
immunoglobulin deposits, which is typically IgG kappa [32].
Three of our specimens had IgG kappa without IgG lambda.
Monoclonal immunoglobulin deposition is more common in
immunotactoid glomerulopathy [32]. Although most of our
specimens had both kappa and lambda light chains in the
immune deposits, the IgG was nevertheless very homogeneous
with respect to subclass composition. IgG4 was dominant in all
specimens, and was the exclusive IgG subclass identified in
most.
As did Korbet et al [9], we wonder whether the homogeneity
of the immunoglobulin in the immune deposits of fibrillary
glomerulonephritis may not be the basis for the formation of the
fibrillar structures. This might be analogous to the formation of
the amyloid fibrils composed of monoclonal light chains, of
similar microtubular tactoids in the deposits of cryoglobuline-
mia (which frequently contain a monoclonal component), and of
microtubules of monoclonal immunoglobulin in immunotactoid
glomerulopathy. Yang et al have demonstrated by immunoelec-
tron microscopy that the fibrils of fibrillary glomerulonephritis
do in fact contain the immunoglobulin observed by immunoflu-
orescence microscopy [33].
The striking dominance of IgG4 in the deposits of fibrillary
glomerulonephritis is even more impressive given the fact that
IgG4 normally accounts for only 0.7 to 4.2% of circulating IgG,
compared to 60.3 to 71.5% for IgGi, 19.4 to 31.0% for IgG2, and
5.0 to 8.4% for IgG3 [34]. Of the IgG subclasses, IgG4 has a
much higher ratio of kappa to lambda light chains (8.0 compared
to 1.1 to 2.4 for the other subclasses) [34]. This latter charac-
teristic is interesting in light of the observation that all of the
reported monoclonal fibrillary glomerulonephritis deposits have
contained kappa light chains [32]. IgG4 does not activate
complement by the classic pathway, but does activate it by the
alternative pathway [35], which would explain the presence of
C3 in the fibrillary glomerulonephritis immune deposits that
have only IgG4.
In conclusion, fibrillary glomerulonephritis is a pathologically
distinctive form of glomerular disease that is characterized by
randomly arranged, approximately 20 nm diameter fibrils ultra-
structurally, and by IgG4 dominant immune deposits by immu-
nofluorescence microscopy. Nephrotic syndrome is the most
common clinical manifestation, with most patients developing
renal failure within four years of diagnosis. We hypothesize that
the relative homogeneity of the immunoglobulin in the immune
deposits is the basis for the fibrillar ultrastructural appearance.
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